# P-glycoproteins and amphids: a two-stage trajectory of ivermectin resistance in Caenorhabditis elegans

**Authors:** Lucas Barat, Eva Guchen, Clara Blancfuney, Marie Garcia, Mélanie Alberich, Anne Lespine, Rémy Betous

PMC · DOI: 10.1016/j.ijpddr.2026.100637 · International Journal for Parasitology: Drugs and Drug Resistance · 2026-02-07

## TL;DR

This study shows how C. elegans develops resistance to ivermectin in two stages, involving early drug efflux and later changes in sensory structures.

## Contribution

The paper identifies a two-stage mechanism of ivermectin resistance involving P-glycoproteins and amphid defects in C. elegans.

## Key findings

- Early ivermectin exposure triggers transient P-glycoprotein overexpression.
- Long-term resistance is linked to ciliary/neuronal pathway remodeling and a Dyf phenotype.
- Three independent lineages converged on similar resistance mechanisms despite genetic differences.

## Abstract

Ivermectin (IVM) is a cornerstone of nematode control. However, its efficacy is increasingly compromised by emerging resistance in target parasites. P-glycoproteins (Pgps), which mediate drug efflux, and amphid neuron defects, characterized by a dye-filling defective (Dyf) phenotype, may both contribute to IVM resistance in Caenorhabditis elegans, but their respective roles and potential connection remain to be clarified. Here, we investigated these mechanisms in three independently evolved Caenorhabditis elegans lineages exposed to stepwise IVM selection. These populations, although distinct, converged over time to a comparable and stabilized high level of IVM resistance. Endpoint transcriptomes revealed fluctuations in the expression of several pgp, overexpressed in one lineage only, suggesting that sustained pgp upregulation is not a conserved feature of stable resistance. Consistently, neither short-term exposure to IVM nor long-term drug pressure selection elicited strong transcriptional induction. Nevertheless, we uncovered a transient surge of several pgp transcripts during the early selection process of the worms exposed to low doses of IVM. We speculate this relates to an early pgp-dependent tolerance mechanism in the dynamic adaptation program to IVM. Beyond an initial pgp-based response, our expanded RNA-seq analysis across lineages revealed a conserved enrichment for ciliary/neuronal pathways including genes expressed in amphid/phasmid, indicating remodeling of the chemosensory/ciliary network as resistance intensifies. All resistant lines also converged on the Dyf phenotype that emerged during selection at stages coinciding with sharp gains in IVM tolerance, implicating amphid structure/function in the establishment of durable resistance. Together, these data reconcile heterogeneous literature on PGPs by decoupling transient, context-dependent pgp activation from long-term maintenance of resistance, and are consistent with previous work showing ciliary pathways as common denominators of IVM resistance. We propose a two-phase associative model in which early PGP-mediated tolerance precedes the emergence of ciliary/amphidial signatures and a Dyf phenotype during selection that durably reduces susceptibility.

Image 1

•Comparison of three independently evolved ivermectin-resistant C. elegans lines.•Two-stage trajectory of ivermectin resistance acquisition.•Early, transient pgp overexpression at low ivermectin doses.•Cross-lineage RNA-seq highlights conserved ciliary/neuronal signatures.•Dyf phenotype co-occurs with sharp increases in ivermectin tolerance.

Comparison of three independently evolved ivermectin-resistant C. elegans lines.

Two-stage trajectory of ivermectin resistance acquisition.

Early, transient pgp overexpression at low ivermectin doses.

Cross-lineage RNA-seq highlights conserved ciliary/neuronal signatures.

Dyf phenotype co-occurs with sharp increases in ivermectin tolerance.

## Linked entities

- **Genes:** PGP (phosphoglycolate phosphatase) [NCBI Gene 283871]
- **Proteins:** PGPS (phosphatidylglycerophosphate synthase, putative)
- **Chemicals:** IVM (PubChem CID 6321424)
- **Species:** Caenorhabditis elegans (taxon 6239)

## Full-text entities

- **Genes:** dyf-7 (Protein dyf-7) [NCBI Gene 181183], dyf-6 (Intraflagellar transport protein 46 homolog) [NCBI Gene 3565899], che-3 (Cytoplasmic dynein 2 heavy chain 1) [NCBI Gene 172593], pgp-5 (P-GlycoProtein related) [NCBI Gene 181276], pgp-9 (P-GlycoProtein related) [NCBI Gene 180165], cdc-42 (Cell division control protein 42 homolog) [NCBI Gene 174233], dyf-2 (WD repeat-containing protein dyf-2) [NCBI Gene 191342], che-11 (WD_REPEATS_REGION domain-containing protein) [NCBI Gene 179666], pgp-13 (P-GlycoProtein related) [NCBI Gene 184845], osm-12 (BBSome complex member bbs-7) [NCBI Gene 190704], avr-14 (Ig-like domain-containing protein;Neurotransmitter-gated ion-channel ligand-binding domain-containing protein) [NCBI Gene 172270], dyf-13 (Intraflagellar transport protein 56 homolog) [NCBI Gene 182970], pgp-8 (P-GlycoProtein related) [NCBI Gene 181277], pgp-10 (P-GlycoProtein related) [NCBI Gene 180981], nhr-8 (Nuclear hormone receptor family member nhr-8) [NCBI Gene 177551], pgp-3 (Multidrug resistance protein pgp-3) [NCBI Gene 181326], glc-1 (Glutamate-gated chloride channel alpha) [NCBI Gene 180086], osm-6 (Intraflagellar transport protein 52 C-terminal domain-containing protein) [NCBI Gene 179631], pgp-11 (P-GlycoProtein related) [NCBI Gene 183971], glc-3 (Ig-like domain-containing protein) [NCBI Gene 178930], pgp-6 (P-GlycoProtein related) [NCBI Gene 181278], avr-15 (Ig-like domain-containing protein;Neurotransmitter-gated ion-channel transmembrane domain-containing protein) [NCBI Gene 179834], dyf-1 (Tetratricopeptide repeat protein 30 homolog) [NCBI Gene 172122], pgp-4 (P-GlycoProtein related) [NCBI Gene 181327], pgp-14 (P-glycoprotein 14) [NCBI Gene 181416], pgp-7 (P-GlycoProtein related) [NCBI Gene 188697], ubr-1 (E3 ubiquitin-protein ligase ubr-1) [NCBI Gene 171953], bbs-8 (Tetratricopeptide repeat protein 8) [NCBI Gene 188904], dyf-11 (TRAF3-interacting protein 1) [NCBI Gene 180421], pgp-1 (Multidrug resistance protein pgp-1) [NCBI Gene 178215], pgp-12 (P-GlycoProtein related) [NCBI Gene 181415], tba-1 (Tubulin alpha chain) [NCBI Gene 172831]
- **Diseases:** paralysis (MESH:D010243), Nematodes (MESH:D009349), Dyf (MESH:D000013), hypersensitivity (MESH:D004342), amphid dysfunction (MESH:D006331), infection (MESH:D007239), toxicity (MESH:D064420)
- **Chemicals:** water (MESH:D014867), DTT (MESH:D004229), CaCl2 (MESH:D002122), glutamate (MESH:D018698), Cholesterol (MESH:D002784), NaOH (MESH:D012972), NaCl (MESH:D012965), IVM (MESH:D007559), nitrogen (MESH:D009584), agar (MESH:D000362), levamisole (MESH:D007978), DMSO (MESH:D004121), Bristol (-), MgSO4 (MESH:D008278), avermectin (MESH:C019264), sodium hypochlorite (MESH:D012973)
- **Species:** Dirofilaria immitis (canine heartworm nematode, species) [taxon 6287], C. elegans [taxon 328850], Escherichia coli (E. coli, species) [taxon 562], Caenorhabditis elegans (species) [taxon 6239], Parascaris sp. (species) [taxon 6255], Onchocerca volvulus (species) [taxon 6282], Teladorsagia circumcincta (species) [taxon 45464], Haemonchus contortus (barber pole worm, species) [taxon 6289], Nematoda (nematode, phylum) [taxon 6231], Bacteria Latreille et al. 1825 (Bacteria stick insect, genus) [taxon 629395], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** N2 — Mus musculus (Mouse), Mouse neuroblastoma, Cancer cell line (CVCL_0470)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12950371/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12950371/full.md

## References

55 references — full list in the complete paper: https://tomesphere.com/paper/PMC12950371/full.md

---
Source: https://tomesphere.com/paper/PMC12950371